COMPIPATCH SEQUI Trademark

Trademark Overview


On Friday, May 25, 2001, a trademark application was filed for COMPIPATCH SEQUI with the United States Patent and Trademark Office. The USPTO has given the COMPIPATCH SEQUI trademark a serial number of 78065700. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, May 21, 2002. This trademark is owned by Vivelle Ventures, LLC. The COMPIPATCH SEQUI trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparation for hormone therapy containing al least one estrogen and at least on progestogen

General Information


Serial Number78065700
Word MarkCOMPIPATCH SEQUI
Filing DateFriday, May 25, 2001
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, May 21, 2002
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicespharmaceutical preparation for hormone therapy containing al least one estrogen and at least on progestogen

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 31, 2001
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVivelle Ventures, LLC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiami, FL 33186

Trademark Events


Event DateEvent Description
Tuesday, May 21, 2002ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, August 29, 2001NON-FINAL ACTION MAILED
Thursday, August 16, 2001ASSIGNED TO EXAMINER